Tom W. J. Huizinga. ‘Although the validation cohort is relatively small and the current prediction rule should be evaluated in other early-arthritis cohorts, we believe that the current model allows doctors and patients to create an evidence-based choice relating to whether or not to initiate DMARDs, in the majority of individuals presenting with UA.’.. A prediction rule for disease end result in patients with recent-onset undifferentiated arthritis Marked by chronic inflammation of the tissue and joints, arthritis rheumatoid is an agonizing and potentially disabling autoimmune disease. An abundance of analysis supports early aggressive treatment with disease-modifying antirheumatic medicines as the very best training course for preventing joint damage and avoiding the fate of a wheelchair.This is why UCB Canada is definitely honoured and privileged to keep such an excellent initiative just like the UCBeyond Scholarship Program – to recognize those individuals that continuously go above and beyond their illness and reach higher plateaus. Related StoriesACR releases 2015 Guideline for Treatment of Rheumatoid ArthritisClinical study data on Mallinckrodt's H.P. Acthar Gel to be provided at ACR 2015Researchers develop novel technology for chronic arthritisAn independent selection committee of leading physicians and individual representatives from across the country will choose the 2010 UCBeyond Scholarship recipients.